Rafael Holdings, Inc. owns commercial real estate assets and interests in preclinical and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey.
| Revenue (TTM) | $1.16M |
| Gross Profit (TTM) | $1.08M |
| EBITDA | $-34.45M |
| Operating Margin | -3154.00% |
| Return on Equity | -41.40% |
| Return on Assets | -23.80% |
| Revenue/Share (TTM) | $0.03 |
| Book Value | $1.52 |
| Price-to-Book | 0.80 |
| Price-to-Sales (TTM) | 55.90 |
| EV/Revenue | 22.64 |
| EV/EBITDA | 5.39 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 174.00% |
| Shares Outstanding | $51.23M |
| Float | $31.19M |
| % Insiders | 37.85% |
| % Institutions | 7.76% |